Huadong Medicine News

Huadong Pharmaceutical: Announcement on the receipt of drug registration certificates by wholly-owned subsidiaries

just now

Huadong Pharmaceutical: Announcement on acceptance of the application for registration and listing of exclusive commercial products

just now

Huadong Pharmaceutical: Announcement on the receipt of drug registration certificates by wholly-owned subsidiaries

just now

Huadong Pharmaceutical: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials

Nov 18 11:00 ET

Huadong Pharmaceutical: Announcement on Wholly-owned Subsidiaries Obtaining US FDA Clinical Trial Approval Notice for New Drugs

Nov 18 11:00 ET

Huadong Pharmaceutical: Notice on Wholly Owned Subsidiaries Obtaining Drug Registration Certificates

Nov 5 11:00 ET

Huadong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining a Notice of Approval for Drug Clinical Trials

Oct 18 12:00 ET

Huadong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining a Notice of Approval for Drug Clinical Trials

Oct 15 12:00 ET

Huadong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining a Notice of Approval for Drug Clinical Trials

Oct 10 12:00 ET

Huadong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining a Notice of Approval for Drug Clinical Trials

Sep 29 12:00 ET

Huadong Pharmaceutical: Announcement on Wholly-owned Subsidiaries Obtaining Medical Device Registration Certificates

Sep 24 12:00 ET

Huadong Pharmaceutical: Announcement on the approval of the wholly-owned subsidiary drug fondaghan decanoate injection from the US FDA

Aug 27 12:00 ET

Huadong Medicine: Announcement on the Implementation of Hedging Financial Derivatives Trading

Aug 15 12:00 ET

Huadong Medicine: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.

Aug 15 12:00 ET

Huadong Medicine: Announcement Regarding the Termination of TTP273 Project Development by Our Wholly-owned Subsidiary.

Aug 15 12:00 ET

Huadong Medicine: Announcement Regarding Exclusive Product Licensing Agreement Signed Between Wholly-owned Subsidiary and IMBiologics Company.

Aug 15 12:00 ET

Huadong Medicine: Financial Report for the first half of 2024.

Aug 15 12:00 ET

Huadong Medicine: Announcement regarding the signing of an exclusive commercial cooperation agreement for products by a wholly-owned subsidiary.

Aug 4 12:00 ET

Huadong Medicine: Announcement regarding the signing of a product collaboration, development, and market promotion service agreement by a wholly-owned subsidiary.

Jul 21 12:00 ET

Huadong Medicine: Announcement Regarding Providing Performance Guarantees to Wholly-owned Subsidiaries.

Jul 21 12:00 ET